Literature DB >> 33404091

In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of human.

Abhigyan Choudhury1, Nabarun Chandra Das1, Ritwik Patra1, Suprabhat Mukherjee1.   

Abstract

COVID-19 pandemic caused by SARS-CoV-2 has already resulted huge setback to mankind in terms of millions of deaths while the unavailability of appropriate therapeutic strategy has made the scenario much more severe. Toll-like receptors (TLRs) are the crucial mediators and regulators of host immunity and the role of human cell surface TLRs in SARS-CoV-2 induced inflammatory pathogenesis has been demonstrated recently. However, the functional significance of the human intracellular TLRs including TLR3,7,8 and 9 is yet unclear. Hitherto, the involvement of these intracellular TLRs in inducing proinflammatory responses in COVID-19 has been reported but the identity of the interacting viral RNA molecule(s) and the corresponding TLRs have not been explored. This study is hoped to rationalize the comparative binding of the major SARS-CoV-2 mRNAs to the intracellular TLRs, considering the solvent-based force-fields operational in the cytosolic aqueous microenvironment that predominantly drives these interactions. Our in-silico study on the binding of all mRNAs with the intracellular TLRs depicts that the mRNA of NSP10, S2, and E proteins of SARS-CoV-2 are possible virus-associated molecular patterns that bind to TLR3, TLR9, and TLR7 respectively and trigger downstream cascade reactions. Intriguingly, binding of the viral mRNAs resulted in variable degrees of conformational changes in the ligand-binding domain of the TLRs ratifying the activation of the downstream inflammatory signaling cascade. Taken together, the current study is a maiden report to describe the role of TLR3, 7, and 9 in COVID-19 immunobiology and could serve as useful targets for the conception of therapeutic strategy against the pandemic. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  COVID-19; Intracellular TLRs; Molecular Docking; Molecular Dynamics (MD) Simulation; NSP10 mRNA; SARS-CoV-2

Year:  2021        PMID: 33404091     DOI: 10.1002/jmv.26776

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  19 in total

Review 1.  Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.

Authors:  Mariya Farooq; Abdul Waheed Khan; Bilal Ahmad; Moon Suk Kim; Sangdun Choi
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

Review 2.  Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity.

Authors:  Mahin Behzadi Fard; Samaneh Behzadi Fard; Shahin Ramazi; Amir Atashi; Zahra Eslamifar
Journal:  Thromb J       Date:  2021-08-23

Review 3.  Chemotherapy vs. Immunotherapy in combating nCOVID19: An update.

Authors:  Abhigyan Choudhury; Gargi Mukherjee; Suprabhat Mukherjee
Journal:  Hum Immunol       Date:  2021-05-18       Impact factor: 2.850

4.  In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein.

Authors:  Nabarun Chandra Das; Pritha Chakraborty; Jagadeesh Bayry; Suprabhat Mukherjee
Journal:  Front Immunol       Date:  2022-01-10       Impact factor: 7.561

5.  Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19.

Authors:  Nikhil Shri Sahajpal; Chi-Yu Jill Lai; Alex Hastie; Ashis K Mondal; Siavash Raeisi Dehkordi; Caspar I van der Made; Olivier Fedrigo; Farooq Al-Ajli; Sawan Jalnapurkar; Marta Byrska-Bishop; Rashmi Kanagal-Shamanna; Brynn Levy; Maximilian Schieck; Thomas Illig; Silviu-Alin Bacanu; Janet S Chou; Adrienne G Randolph; Amyn M Rojiani; Michael C Zody; Catherine A Brownstein; Alan H Beggs; Vineet Bafna; Erich D Jarvis; Alexander Hoischen; Alka Chaubey; Ravindra Kolhe
Journal:  iScience       Date:  2022-01-10

Review 6.  SARS-CoV-2: Receptor and Co-receptor Tropism Probability.

Authors:  Narges Eslami; Parisa Shiri Aghbash; Ali Shamekh; Taher Entezari-Maleki; Javid Sadri Nahand; Abolfazl Jafari Sales; Hossein Bannazadeh Baghi
Journal:  Curr Microbiol       Date:  2022-03-16       Impact factor: 2.343

7.  Association of TLR3 functional variant (rs3775291) with COVID-19 susceptibility and death: a population-scale study.

Authors:  Gunanidhi Dhangadamajhi; Ronnaly Rout
Journal:  Hum Cell       Date:  2021-02-22       Impact factor: 4.174

Review 8.  Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.

Authors:  Sébastien Boutin; Dagmar Hildebrand; Steeve Boulant; Michael Kreuter; Jule Rüter; Srinivas Reddy Pallerla; Thirumalaisamy P Velavan; Dennis Nurjadi
Journal:  Cell Mol Life Sci       Date:  2021-07-05       Impact factor: 9.261

9.  Tracking the amino acid changes of spike proteins across diverse host species of severe acute respiratory syndrome coronavirus 2.

Authors:  Srinivasulu Yerukala Sathipati; Sanjay K Shukla; Shinn-Ying Ho
Journal:  iScience       Date:  2021-12-02

Review 10.  The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy.

Authors:  Eva Ramos; Francisco López-Muñoz; Emilio Gil-Martín; Javier Egea; Iris Álvarez-Merz; Sakshi Painuli; Prabhakar Semwal; Natália Martins; Jesús M Hernández-Guijo; Alejandro Romero
Journal:  Antioxidants (Basel)       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.